The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Cyclodextrins in drug delivery: An updated review
Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060243 · Cited by 1,215
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Nanoparticles – An efficient carrier for drug delivery into the hair follicles
Lademann, J., Richter, H., Teichmann, A., Otberg, N., Blume-Peytavi, U., Luengo, J., Weiß, B., Schaefer, U. F., Lehr, C.-M., & Wepf, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.019 · Cited by 573
Sheddable Coatings for Long-Circulating Nanoparticles
Romberg, B., Hennink, W. E., & Storm, G. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 555
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development
Szente, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00092-1 · Cited by 540
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 499
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06377.x · Cited by 394
Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain
Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 362
Liversidge, G. G., & Conzentino, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00148-c · Cited by 294
Blunk, T., Hochstrasser, D. F., Sanchez, J., Müller, B. W., & Müller, R. H. (1993) · ELECTROPHORESIS · doi:10.1002/elps.11501401214 · Cited by 251
Self-citationNanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
Jacobs, C., Kayser, O., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00412-3 · Cited by 232
Self-citationNanocapsules: A new type of lysosomotropic carrier
Couvreur, P., Tulkenst, P., Roland, M., Trouet, A., & Speiser, P. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)80717-5 · Cited by 197
Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages
Illum, L., Jacobsen, L. O., Müller, R. H., Mak, E., & Davis, S. S. (1987) · Biomaterials · doi:10.1016/0142-9612(87)90099-8 · Cited by 176
Self-citationItraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat
Rabinow, B. E., Kipp, J., Papadopoulos, P., Wong, J., Glosson, J., Gass, J. H., Sun, C.-S., Wielgos, T., White, R., Cook, C. S., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.030 · Cited by 155
Florence, A. T., Hillery, A. M., Hussain, N., & Jani, P. U. (1995) · Journal of drug targeting · doi:10.3109/10611869509015936 · Cited by 154
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
Alyautdin, R. N., Gothier, D., Петров, Kharkevich, D. A., & Kreuter, J. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 148
Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H. H., & Liesenfeld, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00660-3 · Cited by 145
Self-citationThe relationship between particle size and solubility
Buckton, G., & Beezer, A. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90184-4 · Cited by 143
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 140
Self-citationDuodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G. P., & Gasco, M. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10368 · Cited by 133
Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man
Horst, H.-J., H�ltje, W. J., Dennis, M. J., Coert, A., Geelen, J., & Voigt, K. D. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01483589 · Cited by 128
New Method for the Effective Production of Ultrafine Drug Nanocrystals
Möschwitzer, J. P., & Müller, R. H. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.480 · Cited by 100
Self-citationLiposomes: From the Bench to the Bed
Crommelin, D. J. A., & Storm, G. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120017488 · Cited by 81
Kobierski, S., Ofori-Kwakye, K., Müller, R. H., & Keck, C. M. (2009) · Die Pharmazie · doi:10.31083/ph.2009.9097 · Cited by 76
Self-citationCremophor EL-containing paclitaxel-induced anaphylaxis: a call to action
Irizarry, L., Luu, T. H., McKoy, J. M., Samaras, A. T., Fisher, M. J., Carias, E., Raisch, D. W., Calhoun, E. A., & Bennett, C. L. (2009) · Community Oncology · doi:10.1016/s1548-5315(11)70224-8 · Cited by 48
Storm, G., Wilms, H. P., & Crommelin, D. J. A. (1991) · Biotherapy · doi:10.1007/bf02175097 · Cited by 43
Shubar, H. M., Dunay, I. R., Lachenmaier, S., Dathe, M., Bushrab, F. N., Mauludın, R., Müller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2009) · Journal of drug targeting · doi:10.1080/10611860902718680 · Cited by 37
Self-citationLabelled StealthR liposomes in experimental infection: An alternative to leukocyte scintigraphy?
Oyen, W. J. G., Boerman, O. C., Storm, G., van Bloois, L., Koenders, E. B., Crommelin, D. J. A., van der Meer, J. W. M., & Corstens, F. H. M. (1996) · Nuclear Medicine Communications · doi:10.1097/00006231-199609000-00004 · Cited by 35
Lück, M., Schröder, W., Paulke, B. ‐., Blunk, T., & Müller, R. H. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00110-6 · Cited by 35
Self-citationWang, Q., Sun, A. Y., Pardeike, J., Müller, R. H., Simonyi, Á., & Sun, G. Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.022 · Cited by 29
Self-citationGessner, A., Paulke, B. ‐., Müller, R. H., & Göppert, T. M. (2006) · PubMed · Cited by 22
Self-citationsmartCrystals — Review of the Second Generation of Drug Nanocrystals
Keck, C. M., & Müller, R. H. (2011) · doi:10.1201/9780429111570-13 · Cited by 19
Self-citationEncapsulation of Water-Insoluble Drugs in Poly(butyl cyanoacrylate) Nanoparticles
Hekmatara, T., Gelperina, S. E., Vogel, V., Yang, S.-R., & Kreuter, J. (2009) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2009.gr05 · Cited by 18
Nanosuspensions and nanostructured lipid carriers for dermal application
Pardeike, J. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4394 · Cited by 9
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Landovitz, R. J., Donnell, D., Clement, M. E., Hanscom, B., Cottle, L., Coelho, L., Cabello, R., Chariyalertsak, S., Dunne, E. F., Frank, I., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101016 · Cited by 900
Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs
Bolla, G., Sarma, B., & Nangia, A. K. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00987 · Cited by 597
Sosnik, A., das Neves, J., & Sarmento, B. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.07.010 · Cited by 487
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
Junyaprasert, V. B., & Morakul, B. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.005 · Cited by 443
Metadata
- Authors
- Müller, R. H., Gohla, S., & Keck, C. M.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 78
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2026930707
- Cited by
- 702
- References
- 43
- FWCI
- 19.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.